Unknown

Dataset Information

0

Targeting the Wnt signaling pathways in pulmonary arterial hypertension.


ABSTRACT: Pulmonary arterial hypertension (PAH) is a life-threatening disorder that is associated with elevated pulmonary pressures and right heart failure resulting from progressive loss and thickening of small pulmonary arteries. Despite their ability to improve symptoms, current therapies fail to prevent disease progression, leaving lung transplantation as the only therapy in end-stage PAH. To overcome the limitations of current therapies, there is an active search for disease-modifying agents capable of altering the natural history of, and improving clinical outcomes in, PAH. The Wnt signaling pathways have emerged as attractive treatment targets in PAH given their role in the preservation of pulmonary vascular homeostasis and the recent development of Wnt-specific compounds and biological therapies capable of modulating pathway activity. In this review, we summarize the literature describing the role of Wnt signaling in the pulmonary circulation and discuss promising advances in the field of Wnt therapeutics that could lead to novel clinical therapies capable of preventing and/or reversing pulmonary vascular pathology in patients with this devastating disease.

SUBMITTER: de Jesus Perez V 

PROVIDER: S-EPMC4689294 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting the Wnt signaling pathways in pulmonary arterial hypertension.

de Jesus Perez Vinicio V   Yuan Ke K   Alastalo Tero-Pekka TP   Spiekerkoetter Edda E   Rabinovitch Marlene M  

Drug discovery today 20140620 8


Pulmonary arterial hypertension (PAH) is a life-threatening disorder that is associated with elevated pulmonary pressures and right heart failure resulting from progressive loss and thickening of small pulmonary arteries. Despite their ability to improve symptoms, current therapies fail to prevent disease progression, leaving lung transplantation as the only therapy in end-stage PAH. To overcome the limitations of current therapies, there is an active search for disease-modifying agents capable  ...[more]

Similar Datasets

2017-08-23 | GSE67597 | GEO
| S-EPMC4956511 | biostudies-literature
| S-EPMC5288696 | biostudies-literature
| S-EPMC8298123 | biostudies-literature
| S-EPMC5938047 | biostudies-literature
2024-11-20 | GSE274053 | GEO
2003-11-15 | GSE703 | GEO
| S-EPMC9487224 | biostudies-literature
| S-EPMC3123986 | biostudies-literature
| S-EPMC3291089 | biostudies-other